ClariVest Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.1K | Hold |
2
| – | – | ﹤0.01% | 604 |
|
|
2024
Q2 | $1.1K | Hold |
2
| – | – | ﹤0.01% | 604 |
|
|
2024
Q1 | $1.16K | Buy |
+2
| New | +$1.12K | ﹤0.01% | 641 |
|
|
2023
Q4 | – | Sell |
-2
| Closed | -$1K | – | 955 |
|
|
2023
Q3 | $1K | Sell |
2
-23,991
| -100% | -$12.8M | ﹤0.01% | 726 |
|
|
2023
Q2 | $12.5M | Sell |
23,993
-4,500
| -16% | -$2.43M | 0.63% | 39 |
|
|
2023
Q1 | $16.4M | Sell |
28,493
-1,500
| -5% | -$845K | 0.73% | 28 |
|
|
2022
Q4 | $16.5M | Sell |
29,993
-616
| -2% | -$326K | 0.8% | 28 |
|
|
2022
Q3 | $15.5M | Sell |
30,609
-18,147
| -37% | -$10.2M | 0.75% | 29 |
|
|
2022
Q2 | $26.5M | Sell |
48,756
-18,240
| -27% | -$10M | 1.15% | 14 |
|
|
2022
Q1 | $39.6M | Buy |
66,996
+2,606
| +4% | +$1.5M | 1.56% | 9 |
|
|
2021
Q4 | $43M | Sell |
64,390
-1,664
| -3% | -$1.04M | 1.32% | 13 |
|
|
2021
Q3 | $37.7M | Sell |
66,054
-1,149
| -2% | -$631K | 1.22% | 13 |
|
|
2021
Q2 | $33.9M | Sell |
67,203
-3,507
| -5% | -$1.65M | 1.13% | 14 |
|
|
2021
Q1 | $32.3M | Sell |
70,710
-7,560
| -10% | -$3.61M | 1.14% | 16 |
|
|
2020
Q4 | $36.5M | Sell |
78,270
-12,173
| -13% | -$5.71M | 1.24% | 16 |
|
|
2020
Q3 | $39.9M | Sell |
90,443
-27,954
| -24% | -$11.5M | 1.31% | 17 |
|
|
2020
Q2 | $42.9M | Sell |
118,397
-24,291
| -17% | -$8.14M | 1.17% | 19 |
|
|
2020
Q1 | $40.5M | Sell |
142,688
-9,793
| -6% | -$3.09M | 1.21% | 20 |
|
|
2019
Q4 | $49.5M | Sell |
152,481
-13,402
| -8% | -$4.06M | 1.14% | 17 |
|
|
2019
Q3 | $48.3M | Sell |
165,883
-8,295
| -5% | -$2.38M | 1.09% | 19 |
|
|
2019
Q2 | $51.2M | Sell |
174,178
-12,027
| -6% | -$3.31M | 1.15% | 15 |
|
|
2019
Q1 | $51M | Sell |
186,205
-12,949
| -7% | -$3.22M | 1.03% | 18 |
|
|
2018
Q4 | $44.6M | Sell |
199,154
-64,978
| -25% | -$15.2M | 0.96% | 20 |
|
|
2018
Q3 | $64.5M | Sell |
264,132
-19,016
| -7% | -$4.37M | 1.14% | 16 |
|
|
2018
Q2 | $58.7M | Sell |
283,148
-20,308
| -7% | -$4.31M | 1.01% | 18 |
|
|
2018
Q1 | $62.7M | Sell |
303,456
-8,143
| -3% | -$1.71M | 1.08% | 18 |
|
|
2017
Q4 | $59.2M | Buy |
311,599
+67,053
| +27% | +$12.8M | 1.02% | 23 |
|
|
2017
Q3 | $46.3M | Sell |
244,546
-10,624
| -4% | -$1.92M | 1.07% | 20 |
|
|
2017
Q2 | $44.5M | Sell |
255,170
-6,230
| -2% | -$1.05M | 1.08% | 16 |
|
|
2017
Q1 | $40.2M | Sell |
261,400
-11,329
| -4% | -$1.73M | 1% | 18 |
|
|
2016
Q4 | $38.5M | Sell |
272,729
-2,043
| -0.7% | -$301K | 1.03% | 21 |
|
|
2016
Q3 | $43.7M | Sell |
274,772
-7,493
| -3% | -$1.15M | 1.27% | 16 |
|
|
2016
Q2 | $41.7M | Buy |
282,265
+308
| +0.1% | +$45.5K | 1.24% | 24 |
|
|
2016
Q1 | $39.9M | Sell |
281,957
-26,200
| -9% | -$3.51M | 1.21% | 27 |
|
|
2015
Q4 | $43.7M | Buy |
308,157
+59,900
| +24% | +$7.99M | 1.24% | 25 |
|
|
2015
Q3 | $30.4M | Buy |
248,257
+12,800
| +5% | +$1.67M | 0.91% | 39 |
|
|
2015
Q2 | $30.6M | Hold |
235,457
| – | – | 0.91% | 37 |
|
|
2015
Q1 | $31.6M | Buy |
235,457
+13,797
| +6% | +$1.78M | 0.97% | 35 |
|
|
2014
Q4 | $27.8M | Sell |
221,660
-475
| -0.2% | -$57.8K | 0.98% | 35 |
|
|
2014
Q3 | $27M | Sell |
222,135
-22
| -0% | -$2.67K | 0.99% | 33 |
|
|
2014
Q2 | $26.2M | Buy |
222,157
+4,457
| +2% | +$525K | 0.99% | 34 |
|
|
2014
Q1 | $26.2M | Buy |
+217,700
| New | +$25.9M | 1.06% | 29 |
|
Other funds holding TMO
ClariVest Asset Management's TMO Position: Q3 2024 in Review
ClariVest Asset Management held its Thermo Fisher Scientific (TMO) position steady in Q3 2024 at 2 shares worth $1.1K. The position accounts for ﹤0.01% of the portfolio, ranked #604.
ClariVest Asset Management first reported a position in TMO in Q1 2014 and has held it in 42 quarters since. The position peaked at $64.5M in Q3 2018. 2,569 funds tracked by Wall St. Rank hold TMO as of Q3 2024.
- ClariVest Asset Management held 2 shares of Thermo Fisher Scientific worth $1.1K as of Q3 2024.
- ClariVest Asset Management left its Thermo Fisher Scientific share count unchanged in Q3 2024.
- Thermo Fisher Scientific made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #604 holding.
- ClariVest Asset Management first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 42 quarters since.
- ClariVest Asset Management's Thermo Fisher Scientific position peaked at $64.5M in Q3 2018.
- 2,569 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.
Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.